As of Aug 17
| -0.03 / -2.33%|
The 4 analysts offering 12-month price forecasts for Anthera Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 4.00 and a low estimate of 1.75. The median estimate represents a +58.73% increase from the last price of 1.26.
The current consensus among 4 polled investment analysts is to Hold stock in Anthera Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.